Drugs / cyclamax
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00484497 | Sep 2006 → ? | insomnia | Persee Medica | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cyclamax | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00484497 ↗ |
| Modality | Other / unclassified | “The tested intervention consisted of two soft gelatine capsules per day, containing either the dietary supplement (active group) or olive oil (placebo group) for a month.” PMID 20569455 ↗ Jun 2010 |